Phospho-Ser784-VCP drives resistance of pancreatic ductal adenocarcinoma to genotoxic chemotherapies and predicts the chemo-sensitizing effect of VCP inhibitor

Authors

Faliang Wang, Washington University School of Medicine in St. Louis
Kiran Vij, Washington University School of Medicine in St. Louis
Lin Li, Washington University School of Medicine in St. Louis
Paarth Dodhiawala, Washington University School of Medicine in St. Louis
Kian-Huat Lim, Washington University School of Medicine in St. Louis
Jieya Shao, Washington University School of Medicine in St. Louis

Journal

Cancers

Publication Date

10-11-2021

Volume

13

Issue

20

First Page

5076

Document Type

Open Access Publication

DOI

10.3390/cancers13205076

Rights and Permissions

Wang, F.; Vij, K.; Li, L.; Dodhiawala, P.; Lim, K.-H.; Shao, J. Phospho-Ser784-VCP Drives Resistance of Pancreatic Ductal Adenocarcinoma to Genotoxic Chemotherapies and Predicts the Chemo-Sensitizing Effect of VCP Inhibitor. Cancers 2021, 13, 5076. https://doi.org/10.3390/cancers13205076 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Wang, Faliang; Vij, Kiran; Li, Lin; Dodhiawala, Paarth; Lim, Kian-Huat; and Shao, Jieya, "Phospho-Ser784-VCP drives resistance of pancreatic ductal adenocarcinoma to genotoxic chemotherapies and predicts the chemo-sensitizing effect of VCP inhibitor." Cancers. 13, 20. 5076 (2021).
https://digitalcommons.wustl.edu/oa_4/1981

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.